ZyGEM NZ CSO, David Saul, PhD, Leads Partnership to Advance Point-of-Care Diagnostic Screening
Led by ZyGEM NZ CSO, Dr. David Saul, ZyGEM scientists and engineers have partnered with scientists at the University of Otago to design a hand-held analytical tool for on-the-spot diagnostic screening. Awarded nearly $6 million in funding from the New Zealand Ministry of Business, Innovation and Employment Endeavour Fund, the collaboration will develop nucleic extraction capabilities combined with solid-state qPCR. The platform will purify samples, detect the diagnostic marker and report the result in under 15 minutes, allowing frontline workers to quickly determine results at the point-of-care.
This portable screening device has the potential to serve a critical role in addressing world health and environmental challenges such as contaminated water and infectious diseases. The initial model is expected to be available in 2020.